<DOC>
	<DOCNO>NCT00639392</DOCNO>
	<brief_summary>The long-term goal study learn Zoledronic Acid prevent reduce pain sickle cell disease . The goal study learn safety Zoledronic Acid person sickle cell disease experience chronic pain require medical treatment use narcotic .</brief_summary>
	<brief_title>Phase 1 Study Zoledronic Acid Sickle Cell Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>18 year old Male female sickle cell disease Pain related sickle cell disease Patient history health service utilization acute SCDrelated pain Patient history use narcotic analgesic pain control within past 6 month Able tolerate hydration 500 mL D51/2 NS prior Zoledronic Acid placebo Calculated creatinine clearance le 60 mL/min Current active dental problem Recent ( within 6 week ) plan dental jaw surgery ( e.g. , extraction , implant ) History cirrhosis chronic symptomatic liver disease ; acute liver disease History aspirininduced asthma History allergy zoledronic acid similar chemicalentities Pregnant nursing No prior bisphosphonate use Receipt investigational drug within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Sickle cell disease</keyword>
</DOC>